Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -43.59% vs 25.81% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -296.97% vs 5.71% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -26.32% vs -37.35% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 600.00% vs 0.00% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Ocuphire Pharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -43.59% vs 25.81% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -50.00% vs 158.82% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -296.97% vs 5.71% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -698.78% vs -15.49% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -26.32% vs -37.35% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -45.45% vs -28.57% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 600.00% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -50.00% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






